The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world experience with atezolizumab (atezo) in advanced urothelial cancer (UC).
 
Pedro C. Barata
No Relationships to Disclose
 
Dharmesh Gopalakrishnan
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Vadim S. Koshkin
No Relationships to Disclose
 
Moshe Chaim Ornstein
No Relationships to Disclose
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Samuel Haywood
No Relationships to Disclose
 
Patricia A. Rayman
No Relationships to Disclose
 
James Finke
No Relationships to Disclose
 
Marcelo Lamenza
No Relationships to Disclose
 
Sarah Devonshire
No Relationships to Disclose
 
Pam Profusek
Speakers' Bureau - Genentech
Other Relationship - Genentech
 
Kimberly D Allman
Honoraria - Exelixis; Pfizer; Sanofi
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Exelixis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Exelixis; Pfizer; Sanofi
 
Allison Martin
No Relationships to Disclose
 
Jennifer Beach
No Relationships to Disclose
 
Kim Schach
No Relationships to Disclose
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech; Merck
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)